ACADIA Pharmaceuticals Inc (ACAD)

Inventory turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Cost of revenue (ttm)	US$ in thousands	81,841	77,929	73,694	62,923	41,639	26,161	13,675	8,883	10,166	10,314	14,860	17,399	19,141	21,881	20,000	20,268	20,550	20,583	20,471	19,992
Inventory	US$ in thousands	21,949	61,041	71,525	61,936	35,819	20,768	9,199	6,095	6,636	5,844	6,327	7,009	7,881	14,336	10,786	10,311	9,682	7,979	6,210	6,318
Inventory turnover		3.73	1.28	1.03	1.02	1.16	1.26	1.49	1.46	1.53	1.76	2.35	2.48	2.43	1.53	1.85	1.97	2.12	2.58	3.30	3.16

December 31, 2024 calculation

Inventory turnover = Cost of revenue (ttm) ÷ Inventory
= $81,841K ÷ $21,949K
= 3.73

ACADIA Pharmaceuticals Inc's inventory turnover has fluctuated over the years, showing a general declining trend. As of December 31, 2024, the inventory turnover ratio stands at a relatively high 3.73, indicating that the company is efficiently managing its inventory by quickly selling and replenishing goods. However, it is important to note that the inventory turnover has shown a decreasing pattern from 2020 to 2024, with occasional fluctuations along the way. This trend suggests that the company may be experiencing challenges in managing its inventory levels efficiently or in adapting to changes in demand for its products. Further analysis and monitoring of the inventory turnover ratio over time will be necessary to assess the effectiveness of ACADIA Pharmaceuticals Inc's inventory management strategies.